Kaleido Biosciences, Inc.
KLDODelisted Apr 18, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001751299
Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 63
- Q1 2022, −2 vs. previous quarter
- 13F value
- $55.1M
- Reported value at the end of Q1 2022
- Superinvestors holding
- 0
- At the end of Q1 2022
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2021
- $1.10M
- +13.2% year over year
- Net income, FY2021
- -$90.3M
- No comparable prior period
- Free cash flow, FY2021
- -$78.2M
- No comparable prior period
- Revenue, Q4 FY2021
- $492.0K
- +102.5% year over year
Revenue flow, FY2021
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2021: $90.3M (8178.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 67.0K
- Shares sold short
- Change
- −13
- 0.0% vs. previous
- Days to cover
- 44.40
- At average daily volume
Superinvestors holding KLDO, Q1 2022
Go to the superinvestors tabNo superinvestor reported holding KLDO at the end of Q1 2022.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Kaleido Biosciences, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Kaleido Biosciences, Inc. insiders are on file.
Top 10 13F holders, Q1 2022
See all 63 holdersThe largest institutional positions in Kaleido Biosciences, Inc. at the end of Q1 2022; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 19,575,710 | $32.3M | 0.76% | 00.0% | Unchanged |
| FMR LLC | 6,389,660 | $10.5M | 0.00% | +5080.0% | Added |
| HarbourVest Partners LLC | 1,833,832 | $3.03M | 0.62% | 00.0% | Unchanged |
| BlackRock Inc. | 913,506 | $1.51M | 0.00% | −10,325−1.1% | Reduced |
| Vanguard Group Inc | 870,602 | $1.44M | 0.00% | −166,785−16.1% | Reduced |
| Baillie Gifford & Co | 733,525 | $1.21M | 0.00% | +12,013+1.7% | Added |
| Federated Hermes, Inc. | 607,687 | $1.00M | 0.00% | +1,484+0.2% | Added |
| Artal Group S.A. | 500,500 | $826.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 435,024 | $718.0K | 0.00% | +5,037+1.2% | Added |
| Geode Capital Management, LLC | 336,879 | $555.0K | 0.00% | −1,541−0.5% | Reduced |